Direkt zum Inhalt
Merck
  • The 103I variant of the melanocortin 4 receptor is associated with low serum triglyceride levels.

The 103I variant of the melanocortin 4 receptor is associated with low serum triglyceride levels.

The Journal of clinical endocrinology and metabolism (2005-11-10)
Günter Brönner, Alexander M Sattler, Anke Hinney, Muhidien Soufi, Frank Geller, Helmut Schäfer, Bernhard Maisch, Johannes Hebebrand, Juergen R Schaefer
ZUSAMMENFASSUNG

The melanocortin 4 receptor (MC4R) is an essential regulator of energy intake and body weight. Recently, the V103I polymorphism of MC4R has been shown to be negatively associated with body mass index. This suggests that serum lipids and blood pressure in individuals carrying the 103I allele might be influenced as well. The objective of this study was to determine whether the most common polymorphism of the MC4R, V103I, affects serum lipid levels and/or blood pressure. The study participants were 1173 consecutive patients undergoing cardiac catheterization; they were genotyped for the rs2229616 G-->A substitution at codon 103 (V103I polymorphism) of the MC4R gene. Patients had strictly fasted for at least 12 h before blood samples were drawn. The average age of the patients was 60.9 yr; 72% were males. The main outcome measures were body mass index, serum lipids, aortic and systolic blood pressure, and MC4R polymorphism V103I. Heterozygous carriers of the 103I allele had significantly lower triglyceride levels than individuals homozygous for the wild-type allele (127 vs. 168 mg/dl mean total triglyceride; P = 0.001 or 0.009 after Bonferroni adjustment for seven tests). No homozygous carriers of the 103I allele were present in the study population. Our study suggests an influence of MC4R activity on triglyceride levels in cardiovascular patients.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
1,2-Diaminoethantrityl, polymergebunden, 100-200 mesh, extent of labeling: 1.2-1.7 mmol/g loading, 1 % cross-linked